<table id="i1abae56c-4e9f-42af-8231-7c5e9a9f52c6" width="65%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1: Mean pharmacokinetic parameters (% coefficient variation) resulting from a fasting single dose study in normal volunteers and a multiple dose study in patients with cancer pain.</caption>
<tbody>
<tr>
<td>
<content stylecode="bold">Regimen/<br/>Dosage Form<br/>
</content>
</td>
<td>
<content stylecode="bold">AUC#,+<br/>(</content>
<content stylecode="bold">ng.h</content>
<content stylecode="bold">/mL)<br/>
</content>
</td>
<td>
<content stylecode="bold">C<sub>max</sub>+<br/>(ng/mL)<br/>
</content>
</td>
<td>
<content stylecode="bold">T<sub>max</sub>
<br/>(h)<br/>
</content>
</td>
<td>
<content stylecode="bold">C<sub>min</sub>+<br/>(ng/mL)<br/>
</content>
</td>
<td>
<content stylecode="bold">Fluctuation*<br/>
<br/>
</content>
</td>
</tr>
<tr>
<td>Single Dose (n=24)<br/>
</td>
<td>
<br/>
</td>
<td>
<br/>
</td>
<td>
<br/>
</td>
<td>
<br/>
</td>
<td>
<br/>
</td>
</tr>
<tr>
<td>KADIAN® Capsule<br/>
</td>
<td>271.0 (19.4)<br/>
</td>
<td>15.6 (24.4)<br/>
</td>
<td>8.6 (41.1)<br/>
</td>
<td>na^<br/>
</td>
<td>na<br/>
</td>
</tr>
<tr>
<td>Extended-Release Tablet<br/>
</td>
<td>304.3 (19.1)<br/>
</td>
<td>30.5 (32.1)<br/>
</td>
<td>2.5 (52.6)<br/>
</td>
<td>na<br/>
</td>
<td>na<br/>
</td>
</tr>
<tr>
<td>Morphine Solution<br/>
</td>
<td>362.4 (42.6)<br/>
</td>
<td>64.4 (38.2)<br/>
</td>
<td>0.9 (55.8)<br/>
</td>
<td>na<br/>
</td>
<td>na<br/>
</td>
</tr>
<tr>
<td>
<br/>Multiple Dose (n=24)<br/>
</td>
<td>
<br/>
</td>
<td>
<br/>
</td>
<td>
<br/>
</td>
<td>
<br/>
</td>
<td>
<br/>
</td>
</tr>
<tr>
<td>KADIAN® Capsule q24h<br/>
</td>
<td>500.9 (38.6)<br/>
</td>
<td>37.3 (37.7)<br/>
</td>
<td>10.3 (32.2)<br/>
</td>
<td>9.9 (52.3)<br/>
</td>
<td>3.0 (45.5)<br/>
</td>
</tr>
<tr>
<td>Extended-Release Tablet q12h<br/>
</td>
<td>457.3 (40.2)<br/>
</td>
<td>36.9 (42.0)<br/>
</td>
<td>4.4 (53.0)<br/>
</td>
<td>7.6 (60.3)<br/>
</td>
<td>4.1 (51.5)<br/>
</td>
</tr>
</tbody>
</table>